Inclusion Criteria:  Age 20-60 years Body mass index (BMI) ≥30.0 ± 0.1 and ≤40.0 ± 0.1 kg/m2 HbA1c ≤ 5.7 ± 0.1% No history of diabetes (type 1 and type 2) In good general health with no conditions that could influence the outcome of the trial, and in the judgment of the investigator is a good candidate for the study based on review of available medical history, physical examination and clinical laboratory evaluations Willing to adhere to the protocol requirements for the duration of the study  Exclusion Criteria:  Exercises frequently i.e. ≥ 150 minutes per week of moderate intensity or ≥ 75 min high intensity. Blood glucose rises ≥140mg/dl at 2 hours after OGTT on Visit 1 Use of weight loss medications (i.e. GLP-1 agonists) Use of any medications related to diabetes Use of beta-blockers Use of anticoagulation and aspirin Use of agents that affect hepatic glucose production such as beta adrenergic agonists, xanthine derivatives Currently pregnant or breastfeeding Current smoker Heart or lung disease Acute infection, including COVID-19 (current or recent infection of COVID-19 in the previous 3 months) Any hospitalization due to COVID-19. Severe hypertension (systolic >160 mmHg or diastolic >90 mmHg) Inability to exercise for any reason Any known contraindication to exercise testing based on current ACSM guidelines (5)